Philip Mease, MD Alexis R. Ogdie-Beatty, MD

Philip J. Mease, MD, and Alexis R. Ogdie-Beatty, MD, review the pathogenesis and a wide spectrum of clinical features, manifestations, and comorbidities of psoriatic arthritis; talk about classification criteria for PsA and different patient-reported and provider-assessed outcome measures; and discuss treatment recommendations and strategies, as well as various types of current and emerging therapies. Finally, they highlight some of the key issues and challenges of the management of PsA through reviewing patient case studies.

Content Areas

  • Pathogenesis
  • Clinical features, manifestations, and comorbidities
  • Classification criteria
  • Outcomes measures
  • GRAPPA/EULAR and ACR/NPF treatment recommendations
  • Treat-to-target strategy
  • Pharmacologic therapeutic classes
  • PsA care (traditional model vs personalized medicine)
  • Case studies

Target Audience

This activity was developed for rheumatologists, dermatologists, primary care physicians, nurse practitioners, physician assistants and other health care providers who manage patients with psoriatic arthritis (PsA).

Faculty

Alexis R. Ogdie-Beatty, MD

Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Director, Penn Psoriatic Arthritis Clinic
University of Pennsylvania
Philadelphia, Pennsylvania           

Philip J. Mease, MD
Seattle Rheumatology Associates
Swedish Medical Center
University of Washington
Seattle, Washington
Enter your information to begin.
CME Credit
Available Credit: 2.50 AMA PRA Category 1 Credits™.
2.50 AANP Contact Hours
Opens: January 31, 2020
Expires: January 30, 2021
Target Audience: Rheumatologists
Dermatologists
Primary Care Physicians
Nurse Practitioners
Physician Assistants
Other Healthcare Providers
This activity is supported by an independent educational grant from Pfizer.